Search

everythinglearnresearchcommunity

for

Search:↓

Oral finasteride, combined with drospirenone, improved hair loss in 62% of premenopausal women, with no reported side effects.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

Skin and hair aging involves mitochondrial issues, telomere shortening, and hormonal changes, with iron affecting hair loss in pre-menopausal women.

In 2017, Spanish dermatologists commonly prescribed topical minoxidil, oral finasteride, and nutricosmetics for hair loss, with oral contraceptives also used for premenopausal women. Less common were oral dutasteride, due to side effects, and newer, more expensive treatments like topical finasteride and Low-Level Laser Therapy. The conclusion is that there's a need for prescription guidelines due to varied treatment approaches.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Spironolactone treatment increases the amount of testosterone available in the body.

Women with female pattern hair loss may have a higher risk of developing metabolic syndrome.

Bicalutamide mesotherapy improved hair density in women with hair loss and was well received.

Most white Spanish women have a widow's peak, and their hairline measurements could help in hair restoration surgery.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

The Fatty Liver Index (FLI) may not be enough to rule out non-alcoholic fatty liver disease in lean women with polycystic ovary syndrome.

Heavier birth weight may increase the risk of early hair graying in women.

Hair loss in women linked to higher sexual dysfunction risk.

Some women with excess hair growth have a hormone condition that can't be diagnosed by blood or urine tests alone.

Isotretinoin may cause temporary, reversible facial hair growth in some women.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

The main cause of hirsutism in Algerian women is polycystic ovary syndrome, and those affected should be checked for related hormonal issues.

Women generally handle heart enlargement better than men, but it's riskier for them if it occurs; hormones like estrogen offer some protection.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

Women with PCOS are much more likely to have sleep problems and should be checked for them.

A woman with anorexia developed gout from self-induced vomiting.

Iron deficiency is the main cause of hair loss in women, and iron supplements started within 6 months can improve hair health.

The androgen receptor gene doesn't help identify women likely to have female pattern hair loss.

A rare ovarian cancer with a good outlook was found in a woman with unusual hair growth and abdominal symptoms.

Ovarian hyperthecosis should be considered in young women with severe male-like symptoms and can be managed with hormone treatments.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting postmenopausal women, with unclear causes.

Women with certain types of hair loss may have low iron levels.